Volatomics for Diagnosis and Risk Stratification of MASLD: A Proof-Of-Concept Study.

Sinha R, Gillespie SL, Brinkman P, Bassett P, Lockman KA, Jaap AJ, Fallowfield JA, Hayes PC, Plevris JN.

Open source

DOI
10.1111/apt.70176
Published
2025-05-20
Container
Aliment Pharmacol Ther
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/apt.70176,
  title = {Volatomics for Diagnosis and Risk Stratification of MASLD: A Proof-Of-Concept Study.},
  author = {Sinha R and  Gillespie SL and  Brinkman P and  Bassett P and  Lockman KA and  Jaap AJ and  Fallowfield JA and  Hayes PC and  Plevris JN.},
  year = {2025},
  journal = {Aliment Pharmacol Ther},
  doi = {10.1111/apt.70176},
  url = {https://doi.org/10.1111/apt.70176}
}

RIS

TY  - JOUR
TI  - Volatomics for Diagnosis and Risk Stratification of MASLD: A Proof-Of-Concept Study.
AU  - Sinha R
AU  -  Gillespie SL
AU  -  Brinkman P
AU  -  Bassett P
AU  -  Lockman KA
AU  -  Jaap AJ
AU  -  Fallowfield JA
AU  -  Hayes PC
AU  -  Plevris JN.
PY  - 2025
JO  - Aliment Pharmacol Ther
DO  - 10.1111/apt.70176
UR  - https://doi.org/10.1111/apt.70176
ER  - 

APA

R, S., SL, G., P, B., P, B., KA, L., AJ, J., JA, F., PC, H., & JN., P. (2025). Volatomics for Diagnosis and Risk Stratification of MASLD: A Proof-Of-Concept Study.. Aliment Pharmacol Ther. https://doi.org/10.1111/apt.70176

Source records